NICE has recommended dupilumab for adults with uncontrolled COPD and raised eosinophils, citing fewer exacerbations and ...
Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.
Patients receiving the tafasitamab combination achieved a median PFS of 22.4 months, compared with 13.9 months for patients receiving placebo with lenalidomide and rituximab. This represents a 57% ...
15don MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.
Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic ...
The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
News-Medical.Net on MSN
Novel immunotherapy targeting pancreatic cancer shows promising results in phase 1/2 trial
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
Paulick Report on MSN
Jockey Melissa Iorio Remains On Sidelines With ‘Complicated’ Arm Fracture
The 33-year-old jockey recorded her 98th career victory the day before breaking her arm in September ...
With no difference in death or MI, Kevin Bainey says doctors can give medical therapy a good try before sending patients for ...
Ryan Collins is a Doctor of Physical Therapy with Specialized Orthopedic Physical Therapy, which operates an office at Wood River Health's Hope Valley location.
Orphan drug designation is granted by the FDA for therapies treating rare disease affecting fewer than 200,000 patients in the U.S., and provides development incentives including extended market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results